Company / Return on Equity (ROE)
Prestige Consumer Healthcare Return on Equity (ROE) History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
13.0%
FY2024
5-year range
12.1% / 13.0%
FY2020-FY2024
Trend
+7.0%
vs FY2023
Sector context
#33 of 190
Health Care
What the data says
Prestige Consumer Healthcare's return on equity (roe) of 13.0% is higher than 83% of companies in the Health Care sector (FY2024). Return on Equity (ROE) has fluctuated over the past 8 years, ranging from -3.3% in FY2021 to 41.3% in FY2017.
Based on SEC 10-K filings.
13.0% in FY2024 with a 5-year CAGR of +4.5%. Top quartile in the Health Care sector.
Improved from 12.2% to 13.0% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +16.2pp
- 5-Year Change
- +4.5pp
- 10-Year Change
- -
Sector benchmark
Top 17% in Health CareTop 17% of 190This company 13.0% Sector average -50.4%
▼
+125.7% above sector average
Key checks
Key Insights
- In FY2024, return on equity (roe) increased 7.0% year-over-year.
- Currently 63.4pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2021.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | - | - |
| FY2024 | 13.0% | +7.0% |
| FY2023 | 12.1% | -0.2% |
| FY2022 | 12.2% | +471.6% |
| FY2021 | -3.3% | -111.4% |
| FY2020 | 28.8% | +241.4% |
| FY2019 | 8.4% | -37.1% |
| FY2018 | 13.4% | -67.5% |
| FY2017 | 41.3% | +342.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026